Open access
Isoliquiritigenin ameliorates metabolic dysfunction-associated steatotic liver disease by modulating S100A8-associated MAPK signaling and ferroptosis-related processes
Findings support S100A8 as an important mediator of ISL's protective effects and provide a mechanistic basis for its potential application in MASLD.
Ying Zhang, Bing-Qian Li, Ying-Nan Song et al.
· Traditional Medicine Researc... · 0 citations